LIVE

PHG

Koninklijke Philips N.V.

PHG

NYSE·Healthcare·Medical - Specialties·Mkt cap $26.4B

$27.74

+1.99%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$23.75 - $33.44

P/E

163.18

Fwd P/E

15.96

Beta

0.93

Div Yield

3.55%

Avg Vol

1.2M

Shares Out

Mkt Cap

$26.4B

Price action

Price chart

Up 10.9% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

1 risk

  • Average volatility.

Growth

Strong growth ahead

Value

Attractively priced below sector peer average

Momentum

Stable

+0.3% over 3m

Quality

Strong

Mixed fundamentals

Dividend

Solid

3.55% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Jul 28, 2026

Q2 26 RECAP

MAY 6, 2026

Reported EPS of $0.27 vs $0.24 consensus (+12.5% surprise). Revenue of $4.6B vs $4.5B expected (+2.2%). Beat on both top and bottom lines.

EPS beat +12.5%
Rev beat +2.2%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+12.5%

Next: Jul 28, 2026

Revenue trend · last 1Q

Q1 26

$4.6B

Margins · last 1Q

Profit

3.9%

Wall Street consensus

1 analyst · 0% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

0%

Hold

1

100%

Sell

0%

Median Price Target

Latest: Citi · Jul 1, 2026

vs Industry

How PHG stacks vs Medical - Specialties

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.